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End-of-life care for intensive care unit (ICU) patients in
the USA has been well described, but only recently have
reports been published describing this care in Europe
[1–3]. In both cultures, however, the public and physi-
cians have begun to pay more attention to the way in
which death is handled in the ICU. Without question,
end-of-life care in the ICU is undergoing radical transfor-
mation. In order to effect any change, however, we need
to look at what our practices are, what influences our
decisions, and how this affects our care for patients who
are dying in the ICU.
Why monitor end-of-life practice?
Why have discussions about end-of-life care become so
prominent recently? Over the past few years, several
surveys [4–6] have reported dissatisfaction on the part of
families who have had loved ones die in the ICU. These
surveys have convinced both the public and critical care
clinicians that something is amiss, but for a long time
physicians have been reluctant to deal with this difficult
issue. Often, because of the discomfort that accompanies
the emotional turmoil of death and dying, we avoid conver-
sation and rely on other less sensitive means for communi-
cation with families, such as light-hearted quips, or quick,
one-line expressions of sympathy. Consequently, families
often feel abandoned by ICU care givers as their loved
ones deteriorate and as the approach to care is changed
from curative to palliative.
We must commend the efforts of Ferrand et al [7], who
represent the French LATAREA group, for their willing-
ness to examine end-of-life practices across a wide spec-
trum of French ICUs. The major findings of this study were
that despite French legislation to the contrary, withholding
and withdrawal of life sustaining therapies are common
practice in French ICUs. In addition, most decision-making
is done by physicians alone, rather than in collaboration
with families or other members of the critical care team. As
the authors conclude, France does not have official,
sanctioned guidelines for withholding or withdrawing life-
sustaining therapies, which may limit end-of-life decision-
making in the ICU. This study represents a bold,
courageous step toward enhancing care for patients dying
in French ICUs. It illustrates why it is so important that we
are willing to monitor and report our end-of-life practice
patterns, even if it makes us a bit uncomfortable.
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Abstract
Ferrand et al’s recent study of witholding and withdrawing life support in intensive care units in France
reminds us that reporting end-of-life practices is an important step towards enhancing end-of-life care.
The study highlights differences between the parentalistic approach to decision making in Europe, and
the patient autonomy model in the USA. However, the reasons intensivists report for witholding or
withdrawing life support are similar in both cultures. Intensivists in France make decisions despite a
lack of formal guidelines in their country. This study should serve as a stimulus for educating the public
and motivating more groups to monitor their end-of-life practices.


















































The major cultural difference between the USA and Europe
is the parentalistic approach of the latter to end-of-life deci-
sion-making. The LATAREA study reported that patients’
families were informed and involved in only 44% of cases,
and the decision to withhold or withdraw was made by
physicians without involving nursing staff in 46% of cases.
The predominant ethical construct in the USA is patient
autonomy, which should imply full participation in decision-
making by either patients or their surrogates. It is interesting
to note, however, that most recent US surveys demonstrate
a considerable amount of family dissatisfaction with the
quality of communication with ICU care givers [8,9].
Good intentions
The similarity between US and French ICU end-of-life
practices is even more interesting. Despite the lack of
guidelines, as well as obvious cultural differences, the
LATAREA study shows that French intensivists do with-
hold and withdraw life-sustaining therapies, albeit at a
lower rate than do their US counterparts [10]. Just as
importantly, the reasons cited by physicians in France for
limitation of care are strikingly similar to those often
quoted by US intensivists [11–13], with futility and poor
expected quality of life being the most frequently cited
reasons in this study.
These facts tell us that, when physicians come to believe
that the care they provide is unlikely to have any further
benefit, they feel withholding or withdrawal of care to be
appropriate. It is reassuring to know that the intent of care
on the part of physicians across the Atlantic is similar to
that of physicians in France.
Decision-making: ‘who’ or ‘how’?
The LATAREA study should serve as a potent stimulus for
education of the public. We may debate, across cultures,
about who should be involved in the decision-making
process, but the more important point is that the decision
is made. At a time when more and more sophisticated
technology and drugs are being introduced into the inten-
sive care arena, the global medical community must
educate the public that death is ultimately unavoidable.
Patients and families must be helped to realize that there
frequently comes a point during ICU care when most
physicians agree that further aggressive care will not
result in survival and will only prolong the suffering of
patients and their loved ones.
This unanimity of view should serve as an important, reas-
suring message to patients and their families; physicians
want to do their best for patients, and this includes finding
the point at which aggressive care no longer makes sense.
In this context of trust between patients, families and care
givers, mutual, shared decision-making can help patients
to receive the best level of care, with the highest likelihood
of success and in accordance with their wishes. In some
cultures, this trust is implicit, as in the parentalistic model.
In some cultures, this trust must be explicitly developed
and stated, based on patient autonomy. However, in both
models there is much work to be done to identify clearly
our true end-of-life practices and to enhance communica-
tion within the critical care team, as well as between the
team, patients, and families.
Conclusion
The LATAREA study reminds us that simply reporting end-
of-life practices is an important first step in the process of
enhancing end-of-life care. We should applaud the group
for their bravery and, ultimately, for their compassion in
enhancing the quality of care received by their dying
patients in the ICU.
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